tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole

C61H86N12O3Si — CID 158395382

IUPACtert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole
SMILESCc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCNC5(CC5)C4)cccc3[nH]2)N1C.Cc1cccnc1[C@@H]1CCC[C@H](c2nc3cccc(N4CCN(C(=O)OC(C)(C)C)C5(CC5)C4)c3n2COCC[Si](C)(C)C)N1C
InChIInChI=1S/C36H54N6O3Si.C25H32N6/c1-26-12-11-19-37-31(26)28-14-10-16-30(39(28)5)33-38-27-13-9-15-29(32(27)41(33)25-44-22-23-46(6,7)8)40-20-21-42(36(24-40)17-18-36)34(43)45-35(2,3)4;1-17-6-5-13-26-22(17)19-8-4-10-21(30(19)2)24-28-18-7-3-9-20(23(18)29-24)31-15-14-27-25(16-31)11-12-25/h9,11-13,15,19,28,30H,10,14,16-18,20-25H2,1-8H3;3,5-7,9,13,19,21,27H,4,8,10-12,14-16H2,1-2H3,(H,28,29)/t28-,30+;19-,21+/m00/s1
InChIKeyGXMFMOQSCQUCKC-WUHABBDOSA-N
MW1063.53 g/mol
LogP11.65
Rot. Bonds11

About tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole

tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole (PubChem CID 158395382) has the molecular formula C61H86N12O3Si and a molecular weight of 1063.53 g/mol. Its IUPAC name is tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole.

Molecular Properties

Compound Nametert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole
PubChem CID158395382
Molecular FormulaC61H86N12O3Si
Molecular Weight1063.53 g/mol
Exact Mass1062.67
IUPAC Nametert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole
SMILESCc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCNC5(CC5)C4)cccc3[nH]2)N1C.Cc1cccnc1[C@@H]1CCC[C@H](c2nc3cccc(N4CCN(C(=O)OC(C)(C)C)C5(CC5)C4)c3n2COCC[Si](C)(C)C)N1C
InChIInChI=1S/C36H54N6O3Si.C25H32N6/c1-26-12-11-19-37-31(26)28-14-10-16-30(39(28)5)33-38-27-13-9-15-29(32(27)41(33)25-44-22-23-46(6,7)8)40-20-21-42(36(24-40)17-18-36)34(43)45-35(2,3)4;1-17-6-5-13-26-22(17)19-8-4-10-21(30(19)2)24-28-18-7-3-9-20(23(18)29-24)31-15-14-27-25(16-31)11-12-25/h9,11-13,15,19,28,30H,10,14,16-18,20-25H2,1-8H3;3,5-7,9,13,19,21,27H,4,8,10-12,14-16H2,1-2H3,(H,28,29)/t28-,30+;19-,21+/m00/s1
InChIKeyGXMFMOQSCQUCKC-WUHABBDOSA-N
XLogP11.65
TPSA136.04 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms77
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001063.53
LogP ≤ 511.65
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole?
The IUPAC name of tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole (CID 158395382) is tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole.
What is the SMILES notation for tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole?
The canonical SMILES for tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole is Cc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCNC5(CC5)C4)cccc3[nH]2)N1C.Cc1cccnc1[C@@H]1CCC[C@H](c2nc3cccc(N4CCN(C(=O)OC(C)(C)C)C5(CC5)C4)c3n2COCC[Si](C)(C)C)N1C.
What is the InChIKey of tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole?
The InChIKey is GXMFMOQSCQUCKC-WUHABBDOSA-N. The full InChI is InChI=1S/C36H54N6O3Si.C25H32N6/c1-26-12-11-19-37-31(26)28-14-10-16-30(39(28)5)33-38-27-13-9-15-29(32(27)41(33)25-44-22-23-46(6,7)8)40-20-21-42(36(24-40)17-18-36)34(43)45-35(2,3)4;1-17-6-5-13-26-22(17)19-8-4-10-21(30(19)2)24-28-18-7-3-9-20(23(18)29-24)31-15-14-27-25(16-31)11-12-25/h9,11-13,15,19,28,30H,10,14,16-18,20-25H2,1-8H3;3,5-7,9,13,19,21,27H,4,8,10-12,14-16H2,1-2H3,(H,28,29)/t28-,30+;19-,21+/m00/s1.
What are the key properties of tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole?
tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole has a molecular weight of 1063.53 g/mol, XLogP of 11.65, 11 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 7-[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-(2-trimethylsilylethoxymethyl)benzimidazol-4-yl]-4,7-diazaspiro[2.5]octane-4-carboxylate;4-(4,7-diazaspiro[2.5]octan-7-yl)-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole is sourced from PubChem (CID 158395382), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).